Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Wegovy producing 14.9% average weight loss in its Phase 3 trial was, at the time, the most effective obesity medication ever approved
Handling tip Allow refrigerated vial to reach room temperature before opening to avoid condensation inside the vial
Dose reduction or slower titration schedules can help manage symptoms whilst maintaining glycaemic control
Recognition of Healthcare Burden: There is an ever-increasing awareness that treating obesity results in meaningful improvement in cardiovascular outcomes and lowers the risk of developing multiple related cardiometabolic diseases including Type 2 Diabetes Mellitus (T2DM), chronic kidney disease (CKD), heart failure, fatty liver or MASH, obstructive sleep apnea (OSA), and peripheral arterial disease (PAD), moving the needle beyond aesthetics and towards total health improvement
6.0 6.1 6.2 6.3 Yasko, Amy (2013), "Your SIMPLIFIED Road Map to Health" (PDF), Neurological Research Institute Regland, B
US$ 20.95
US$ 27.09
US$ 27.30
US$ 20.86
